http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2013005443-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2488e0b44b45f071a0f0d4ba0d332965 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate | 2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a464619fb3a2e370d7fd61331477cae |
| publicationDate | 2013-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2013005443-A |
| titleOfInvention | DERIVATIVES OF BENZODIAZEPIN, COMPOSITIONS AND METHODS TO TREAT COGNITIVE DETERIORATION. |
| abstract | The present invention relates to benzodiazepine derivatives, to compositions comprising therapeutically effective amounts of those benzodiazepine derivatives and methods of use of those derivatives or compositions in the treatment of disorders of the central nervous system (CNS) with cognitive impairment. , which respond to GABAA receptor agonists containing the a5 subunit, for example, age-related cognitive impairment, Mild Cognitive Impairment (MCI), dementia, Alzheimer's disease (AD), prodromal AD, post-stress disorder Traumatic (PTSD), schizophrenia and cognitive impairment related to cancer therapy. |
| priorityDate | 2010-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.